Literature DB >> 22940414

Proton-induced cross sections relevant to production of 225Ac and 223Ra in natural thorium targets below 200 MeV.

J W Weidner1, S G Mashnik, K D John, F Hemez, B Ballard, H Bach, E R Birnbaum, L J Bitteker, A Couture, D Dry, M E Fassbender, M S Gulley, K R Jackman, J L Ullmann, L E Wolfsberg, F M Nortier.   

Abstract

Cross sections for (223,)(225)Ra, (225)Ac and (227)Th production by the proton bombardment of natural thorium targets were measured at proton energies below 200 MeV. Our measurements are in good agreement with previously published data and offer a complete excitation function for (223,)(225)Ra in the energy range above 90 MeV. Comparison of theoretical predictions with the experimental data shows reasonable-to-good agreement. Results indicate that accelerator-based production of (225)Ac and (223)Ra below 200 MeV is a viable production method. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22940414     DOI: 10.1016/j.apradiso.2012.07.006

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  8 in total

Review 1.  Alpha-Emitters and Targeted Alpha Therapy in Oncology: from Basic Science to Clinical Investigations.

Authors:  Mehran Makvandi; Edouard Dupis; Jonathan W Engle; F Meiring Nortier; Michael E Fassbender; Sam Simon; Eva R Birnbaum; Robert W Atcher; Kevin D John; Olivier Rixe; Jeffrey P Norenberg
Journal:  Target Oncol       Date:  2018-04       Impact factor: 4.493

Review 2.  Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside.

Authors:  Stephen Ahenkorah; Irwin Cassells; Christophe M Deroose; Thomas Cardinaels; Andrew R Burgoyne; Guy Bormans; Maarten Ooms; Frederik Cleeren
Journal:  Pharmaceutics       Date:  2021-04-21       Impact factor: 6.321

Review 3.  A Critical Review of Alpha Radionuclide Therapy-How to Deal with Recoiling Daughters?

Authors:  Robin M de Kruijff; Hubert T Wolterbeek; Antonia G Denkova
Journal:  Pharmaceuticals (Basel)       Date:  2015-06-10

4.  Simultaneous Separation of Actinium and Radium Isotopes from a Proton Irradiated Thorium Matrix.

Authors:  Tara Mastren; Valery Radchenko; Allison Owens; Roy Copping; Rose Boll; Justin R Griswold; Saed Mirzadeh; Lance E Wyant; Mark Brugh; Jonathan W Engle; Francois M Nortier; Eva R Birnbaum; Kevin D John; Michael E Fassbender
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

5.  Separation of 103Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide 103mRh.

Authors:  Tara Mastren; Valery Radchenko; Philip D Hopkins; Jonathan W Engle; John W Weidner; Roy Copping; Mark Brugh; F Meiring Nortier; Eva R Birnbaum; Kevin D John; Michael Ernst-Heinrich Fassbender
Journal:  PLoS One       Date:  2017-12-22       Impact factor: 3.240

Review 6.  An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth.

Authors:  Alfred Morgenstern; Christos Apostolidis; Clemens Kratochwil; Mike Sathekge; Leszek Krolicki; Frank Bruchertseifer
Journal:  Curr Radiopharm       Date:  2018

Review 7.  What is the potential impact of the IsoDAR cyclotron on radioisotope production: a review.

Authors:  Loyd H Waites; Jose R Alonso; Roger Barlow; Janet M Conrad
Journal:  EJNMMI Radiopharm Chem       Date:  2020-02-03

Review 8.  Supply and Clinical Application of Actinium-225 and Bismuth-213.

Authors:  Alfred Morgenstern; Christos Apostolidis; Frank Bruchertseifer
Journal:  Semin Nucl Med       Date:  2020-02-21       Impact factor: 4.446

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.